BR0316319A - Derivados de bacterioclorofila aniÈnicos solúveis em água e seus usos - Google Patents
Derivados de bacterioclorofila aniÈnicos solúveis em água e seus usosInfo
- Publication number
- BR0316319A BR0316319A BR0316319-9A BR0316319A BR0316319A BR 0316319 A BR0316319 A BR 0316319A BR 0316319 A BR0316319 A BR 0316319A BR 0316319 A BR0316319 A BR 0316319A
- Authority
- BR
- Brazil
- Prior art keywords
- water soluble
- derivatives
- soluble anionic
- bchls
- pentacyclic
- Prior art date
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title abstract 3
- -1 anionic bacteriochlorophyll derivatives Chemical class 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000000129 anionic group Chemical group 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 1
- 238000002428 photodynamic therapy Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/062—Photodynamic therapy, i.e. excitation of an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0076—PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0036—Porphyrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0624—Apparatus adapted for a specific treatment for eliminating microbes, germs, bacteria on or in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic System
- C07F1/08—Copper compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic System
- C07F13/005—Compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
- C07F15/006—Palladium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
- C07F15/006—Palladium compounds
- C07F15/0066—Palladium compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
- C07F15/04—Nickel compounds
- C07F15/045—Nickel compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic System
- C07F3/02—Magnesium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic System
- C07F3/06—Zinc compounds
Abstract
"DERIVADOS DE BACTERIOCLOROFILA ANIÈNICOS SOLúVEIS EM áGUA E SEUS USOS". A presente invenção refere-se a derivados de bacteriociorofila tetracíclicos e pentacíclicos solúveis em água aniónicos (Bchls) contendo pelo menos um, de preferência dois ou três, grupos negativamente carregados e/ou grupos ácidos que são convertidos em grupos negativamente carregados no pH fisiológico, de preferência Bchls tendo um grupo COO¬ -¬, COS¬ -¬, SO~ 3~¬ -¬ PO~ 3~¬ 2-¬, COOH, COSH, SO~ 3H e/ou PO~ 3~H~ 2~ ligado através de uma ligação éster ou amida a uma ou mais das posições 17¬ 3¬, 13¬ 3¬ e 3¬ 2¬ da molécula de Bchl tetracíclica ou pentacíclica, para terapia fotodinâmica e diagnóstico.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL15290002A IL152900A0 (en) | 2002-11-17 | 2002-11-17 | Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses |
IL152900 | 2002-11-17 | ||
PCT/IL2003/000973 WO2004045492A2 (en) | 2002-11-17 | 2003-11-17 | Water-soluble anionic bacteriochlorophyll derivatives and their uses |
Publications (3)
Publication Number | Publication Date |
---|---|
BR0316319A true BR0316319A (pt) | 2005-09-27 |
BRPI0316319B1 BRPI0316319B1 (pt) | 2017-06-27 |
BRPI0316319B8 BRPI0316319B8 (pt) | 2021-05-25 |
Family
ID=30011928
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0316319A BRPI0316319B8 (pt) | 2002-11-17 | 2003-11-17 | derivados de bacterioclorofila aniônicos solúveis em água, composição farmacêutica, usos dos derivados e método para preparo dos mesmos |
Country Status (24)
Country | Link |
---|---|
US (6) | US7947672B2 (pt) |
EP (2) | EP1567147B1 (pt) |
JP (3) | JP4922559B2 (pt) |
CN (2) | CN102002048B (pt) |
AU (1) | AU2003282354C1 (pt) |
BE (1) | BE2018C018I2 (pt) |
BR (1) | BRPI0316319B8 (pt) |
CA (1) | CA2506296C (pt) |
CY (2) | CY1115458T1 (pt) |
DK (1) | DK1567147T3 (pt) |
ES (1) | ES2489516T3 (pt) |
FR (1) | FR18C0002I2 (pt) |
HK (1) | HK1081858A1 (pt) |
HU (1) | HUS1800020I1 (pt) |
IL (2) | IL152900A0 (pt) |
LU (1) | LUC00073I2 (pt) |
MX (1) | MXPA05005262A (pt) |
NL (1) | NL300934I2 (pt) |
NO (2) | NO334978B1 (pt) |
NZ (1) | NZ540790A (pt) |
PL (1) | PL216661B1 (pt) |
PT (1) | PT1567147E (pt) |
RU (1) | RU2353624C2 (pt) |
WO (1) | WO2004045492A2 (pt) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL152900A0 (en) * | 2002-11-17 | 2003-06-24 | Yeda Res & Dev | Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses |
HUE030586T2 (en) | 2004-06-07 | 2017-06-28 | Yeda Res & Dev | Cationic bacteriochlorophyll derivatives and their uses |
US9957293B2 (en) * | 2006-08-23 | 2018-05-01 | Yeda Research And Development Company Ltd. | Conjugates of RGD peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses |
EP2257309B1 (en) | 2008-02-27 | 2019-10-16 | Yeda Research And Development Company Ltd. | Rgd-(bacterio)chlorophyll conjugates for use in diagnosis of tumors comprising necrotic domains |
EP2425873A1 (fr) | 2010-09-07 | 2012-03-07 | Steba Maor SA | Modélisation de l'action d'une fibre optique dans un traitement par therapie photodynamique, et assistance à la planification d'un tel traitement |
BR112013023162A2 (pt) | 2011-03-11 | 2017-07-25 | Abenhaim Lucien | métodos de terapia fotodinâmica focal |
PT2747763T (pt) | 2011-08-23 | 2021-02-22 | Yeda Res & Dev | Fotossensibilizadores de (bacterio)clorofila para o tratamento de doenças e distúrbios oculares |
EP2971026B1 (en) | 2013-03-11 | 2020-11-18 | Tookad Ip Sarl | Method for producing bacteriochlorophyll a |
CA2907356C (en) | 2013-03-15 | 2022-07-12 | Sherri Ann MCFARLAND | Metal-based coordination complexes as photodynamic compounds and their use |
RU2021110230A (ru) * | 2016-04-10 | 2021-05-26 | Йеда Рисерч Энд Дивелопмент Ко. Лтд. | Комбинированные способы терапии для лечения злокачественной опухоли |
CN107987081B (zh) * | 2016-10-26 | 2019-12-06 | 刘辉 | 一种二氢卟吩e6衍生物及其药学上可接受的盐、其制备方法和应用 |
AU2017384348B2 (en) * | 2016-12-22 | 2024-03-07 | Daiichi Sankyo Company, Limited | Peptide for treating age-related macular degeneration |
US10933134B2 (en) | 2017-03-16 | 2021-03-02 | Memorial Sloan Kettering Cancer Center | Combination therapies for treatment of cancer |
WO2019116376A1 (en) * | 2017-12-17 | 2019-06-20 | Yeda Research And Development Co. Ltd. | Cop9 signalosome (csn) complex modulators and uses thereof |
CN111848656B (zh) * | 2020-06-24 | 2023-03-14 | 天津大学 | 离子修饰的原卟啉镓化合物及其制备方法和应用 |
CN116033913A (zh) * | 2020-07-29 | 2023-04-28 | 国立大学法人北陆先端科学技术大学院大学 | 癌症的治疗药或诊断药 |
CN115843960A (zh) * | 2022-11-03 | 2023-03-28 | 中国农业科学院农产品加工研究所 | 一种提高叶绿素稳定性的方法 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4512762A (en) | 1982-11-23 | 1985-04-23 | The Beth Israel Hospital Association | Method of treatment of atherosclerosis and a balloon catheter for same |
US4693885A (en) * | 1984-07-18 | 1987-09-15 | Nippon Petrochemicals Co., Ltd. | Tetrapyrrole therapeutic agents |
US4675338A (en) * | 1984-07-18 | 1987-06-23 | Nippon Petrochemicals Co., Ltd. | Tetrapyrrole therapeutic agents |
US4977177A (en) * | 1985-04-30 | 1990-12-11 | Nippon Petrochemicals Company, Ltd. | Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents |
US4656186A (en) * | 1985-04-30 | 1987-04-07 | Nippon Petrochemicals Co., Ltd. | Tetrapyrrole therapeutic agents |
JPS63196586A (ja) * | 1987-02-12 | 1988-08-15 | Toyo Hatsuka Kogyo Kk | バクテリオフエオホ−バイド誘導体 |
DE3853995T2 (de) * | 1987-04-17 | 1995-11-23 | David H Dolphin | Porphyrine, verfahren zu deren herstellung und verwendungen. |
US5004811A (en) | 1987-12-24 | 1991-04-02 | Nippon Petrochemicals Company, Ltd. | Tetrapyrrole aminocarboxylic acids |
US5171741A (en) * | 1989-04-21 | 1992-12-15 | Health Research, Inc. | Bacteriochlorophyll-a derivatives useful in photodynamic therapy |
DE4121876A1 (de) * | 1991-07-02 | 1993-01-14 | Scheer Hugo | Modifizierte bakteriochlorophylle, verfahren zu ihrer herstellung und ihre verwendung |
JP3191223B2 (ja) * | 1991-10-04 | 2001-07-23 | 株式会社光ケミカル研究所 | ポルフィリン誘導体とその用途 |
JPH08506566A (ja) * | 1992-06-19 | 1996-07-16 | ザ・ユニバーシティ・オブ・トリド | ポルフィリン系イミンの製造方法及び使用方法 |
IL102645A (en) * | 1992-07-26 | 1998-02-22 | Yeda Res & Dev | Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
US6147195A (en) * | 1993-07-26 | 2000-11-14 | Yeda Research And Development Co., Ltd. | Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
FR2712493B1 (fr) * | 1993-11-16 | 1996-01-19 | Centre Nat Rech Scient | Utilisation de photosensibilisateurs dérivés du noyau phorbine pour la décontamination du sang infecté par des parasites et/ou des virus. |
JPH09110872A (ja) | 1995-10-23 | 1997-04-28 | Eiken Chem Co Ltd | ヨードポルフィリン誘導体 |
IL116126A0 (en) | 1995-11-24 | 1996-01-31 | Yeda Res & Dev | Process for the preparation of bacteriochlorophyllis some novel compounds of this type and pharmaceutical compositions comprising them |
GB9524553D0 (en) * | 1995-11-30 | 1996-01-31 | Britton Charles J | Plastic lever lid tins |
US5770730A (en) * | 1996-03-08 | 1998-06-23 | Health Research, Inc. | Synthesis of carbodimide analogs of chlorins and bacteriochlorins and their use for diagnosis and treatment of cancer |
US6063777A (en) * | 1996-10-01 | 2000-05-16 | Wyeth Lederle Japan, Ltd. | Iminochlorinaspartic acid derivatives |
IL129929A0 (en) * | 1996-12-17 | 2000-02-29 | Du Pont | Polymerization of ethylene with specific iron or cobalt complexes novel pyridinebis (imines) and novel complexes of pyridinebis(imines) with iron and cobalt |
DE69934328T2 (de) * | 1998-12-09 | 2007-07-19 | Yeda Research And Development Co., Ltd. | Palladiumsubstituierte bakteriochlorophyllderivate und deren verwendung |
IL133253A0 (en) | 1999-12-01 | 2001-04-30 | Yeda Res & Dev | Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them |
JP4277159B2 (ja) | 2000-06-02 | 2009-06-10 | 独立行政法人科学技術振興機構 | 新規なテトラピロリル置換ポルフィリン及びその製法 |
WO2002013820A1 (en) | 2000-08-11 | 2002-02-21 | Ceramoptec Industries, Inc. | Photosensitizing ointment |
WO2002098882A1 (en) | 2001-06-01 | 2002-12-12 | Ceramoptec Industries, Inc. | Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture |
IL152900A0 (en) * | 2002-11-17 | 2003-06-24 | Yeda Res & Dev | Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses |
-
2002
- 2002-11-17 IL IL15290002A patent/IL152900A0/xx unknown
-
2003
- 2003-11-17 CA CA2506296A patent/CA2506296C/en not_active Expired - Lifetime
- 2003-11-17 JP JP2004553058A patent/JP4922559B2/ja not_active Expired - Lifetime
- 2003-11-17 AU AU2003282354A patent/AU2003282354C1/en not_active Expired
- 2003-11-17 MX MXPA05005262A patent/MXPA05005262A/es active IP Right Grant
- 2003-11-17 CN CN2010105268579A patent/CN102002048B/zh not_active Expired - Lifetime
- 2003-11-17 RU RU2005118771/13A patent/RU2353624C2/ru active
- 2003-11-17 WO PCT/IL2003/000973 patent/WO2004045492A2/en active Search and Examination
- 2003-11-17 US US10/534,692 patent/US7947672B2/en active Active
- 2003-11-17 CN CN2003801089065A patent/CN1741801B/zh not_active Expired - Lifetime
- 2003-11-17 BR BRPI0316319A patent/BRPI0316319B8/pt active IP Right Grant
- 2003-11-17 EP EP03773967.9A patent/EP1567147B1/en not_active Expired - Lifetime
- 2003-11-17 ES ES03773967.9T patent/ES2489516T3/es not_active Expired - Lifetime
- 2003-11-17 PL PL376734A patent/PL216661B1/pl unknown
- 2003-11-17 EP EP20120161201 patent/EP2522349A1/en not_active Withdrawn
- 2003-11-17 NZ NZ540790A patent/NZ540790A/en not_active IP Right Cessation
- 2003-11-17 PT PT37739679T patent/PT1567147E/pt unknown
- 2003-11-17 DK DK03773967.9T patent/DK1567147T3/da active
-
2005
- 2005-05-09 IL IL168480A patent/IL168480A/en active IP Right Grant
- 2005-06-15 NO NO20052925A patent/NO334978B1/no not_active IP Right Cessation
-
2006
- 2006-02-17 HK HK06102165.9A patent/HK1081858A1/xx not_active IP Right Cessation
-
2010
- 2010-11-09 US US12/942,938 patent/US8461142B2/en not_active Expired - Lifetime
-
2011
- 2011-04-25 JP JP2011096875A patent/JP5566945B2/ja not_active Expired - Fee Related
- 2011-04-25 JP JP2011096876A patent/JP5555659B2/ja not_active Expired - Fee Related
-
2013
- 2013-05-08 US US13/890,126 patent/US20130345417A1/en not_active Abandoned
-
2014
- 2014-08-07 CY CY20141100619T patent/CY1115458T1/el unknown
- 2014-10-01 US US14/504,347 patent/US20150238773A1/en not_active Abandoned
-
2017
- 2017-02-06 US US15/425,473 patent/US20170143988A1/en not_active Abandoned
-
2018
- 2018-04-10 NO NO2018012C patent/NO2018012I2/no unknown
- 2018-04-11 LU LU00073C patent/LUC00073I2/fr unknown
- 2018-04-17 FR FR18C0002C patent/FR18C0002I2/fr active Active
- 2018-04-25 HU HUS1800020C patent/HUS1800020I1/hu unknown
- 2018-04-26 NL NL300934C patent/NL300934I2/nl unknown
- 2018-05-02 BE BE2018C018C patent/BE2018C018I2/nl unknown
- 2018-05-04 CY CY2018012C patent/CY2018012I1/el unknown
-
2019
- 2019-04-29 US US16/397,515 patent/US20200094069A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0316319A (pt) | Derivados de bacterioclorofila aniÈnicos solúveis em água e seus usos | |
EP1496076A4 (en) | HYDROPHILIC Y-BRANCH POLYMER DERIVATIVE AND METHOD OF MANUFACTURING THEREOF; ABOVE CONNECTED MEDICAL COMPOSITE | |
BRPI0212172A8 (pt) | agente fotossensibilizante ou um sal farmaceuticamente aceitável do mesmo, processo para a preparação do mesmo, composição farmacêutica, uso do dito agente ou de um sal farmaceuticamente aceitável do mesmo, método para a introdução de uma molécula de transferência no citosol de uma célula, método para tratamento fotoquimioterapêutico de distúrbios ou anormalidades de superfícies externas ou internas do corpo, produto, kit para uso em fotoquimioterapia de distúbios ou anormalidades de superfícies externas ou internas do corpo, e, método para diagnose in vitro de anormalidades ou distúrbios através da análise de uma amostra do fluido do corpo ou do tecido de um paciente | |
BR0116381A (pt) | Conjugado, composição farmacêutica que compreende o mesmo e sua utilização, processo para o tratamento profilático e/ou terapêutico de distúrbios, processo para a preparação de um conjugado, compostos e glicoproteìnas de eritropoetina | |
ATE219363T1 (de) | Lösliche prodrugs von paclitaxel | |
BR9815442A (pt) | Liberação terapêutica dirigida de compostos de vitamina d | |
BR0011823A (pt) | Derivado de benzimidazol, composto, composição farmacêutica, uso de um derivado de benzimidazol, e, método para tratamento, prevenção ou alìvio de uma doença ou de um distúrbio ou de uma condição de um corpo animal vivo | |
WO2007023398A3 (en) | Compounds for photochemotherapy | |
BRPI0407475A (pt) | Alcalóides terpênicos antiparasitários | |
DE602004027888D1 (de) | Anti-cd70 antikörper-arzneimittelkonjugate und ihr | |
WO2003075850A3 (en) | Methods for alzheimer's disease treatment and cognitive enhancement | |
DK1381611T3 (da) | Metalsubstituerede ikke-centrosymmetriske phthalocyaninanaloger, fremstilling heraf og anvendelse i fotodynamisk terapi samt in vivo diagnostik | |
EA200301063A1 (ru) | Фармацевтические агенты для лечения ганв и микроаденом | |
BR112023006337A2 (pt) | Produto farmacêutico, uso de um conjugado anticorpo anti-her2-fármaco ou um inibidor seletivo de parp1, e, método de tratamento do câncer | |
WO2004004641A3 (en) | PKC ACTIVATION AS A MEANS FOR ENHANCING sAPPα SECRETION AND IMPROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDS | |
WO2013048022A3 (ko) | 수용해도 및 수분산성이 향상된 α-형태의 아연-프탈로시아닌 나노와이어, α-형태의 아연-프탈로시아닌 나노와이어/페노티아진 복합체, 및 이의 제조방법 | |
EP2236129A3 (en) | Liposomal ALA Pharmaceutical and Cosmeceutical Compositions and Methods of Treatment | |
TR200002078T2 (tr) | Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar. | |
MA31630B1 (fr) | Dérivés de 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamides et de 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazépine-7-carboxamides, leur préparation et leur application en thérapeutique | |
TR199902775T2 (xx) | 20(S)-Kamptotesin glikokonjugeleri. | |
BRPI0520482A2 (pt) | amidas do ácido 4-amino-tieno [3,2-c] piridina-7-carboxìlico | |
SE8500996D0 (sv) | Method of treatment | |
WO2004058268A3 (de) | Verwendung von tetrahydrobiopterinderivaten zur behandlung und ernährung von patienten mit aminosäurestoffwechselstörungen | |
CN102532237A (zh) | 喜树碱10位胆酸偶合物及其制备方法 | |
ES2177769T3 (es) | Derivado de aminotetralina para la terapia de trastornos cardiovascu lares. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: PARA:INT.CI. A61K 31/40, A61P 35/00, A61P 31/00 Ipc: A61K 31/40 (2011.01), A61P 35/00 (2011.01), A61P 3 |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] | ||
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/11/2003 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |